Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bevan

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
European Journal of Clinical Investigation|August 24, 1999
Induction of myocardial nitric oxide synthase by Coxsackie B3 virus in miceN M Robinson, H Y Zhang, A L Bevan, et al.
The EMBO Journal|September 8, 2025
Resistance to CDK7 inhibitors directed by acquired mutation of a conserved residue in cancer cellsChun-Fui Lai, Victoria I Cushing, Ellen Olden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogensHayley C Whitaker, Sarah Hanrahan, Nick Totty, et al.
Nursing Ethics|May 8, 2012
Critical social theory approach to disclosure of genomic incidental findingsJeffrey L Bevan, Julia N Senn-Reeves, Ben R Inventor, et al.
Oncogene|February 18, 2004
Androgens target prohibitin to regulate proliferation of prostate cancer cellsSimon C Gamble, Michael Odontiadis, Jonathan Waxman, et al.
Journal of Medical Virology|March 26, 2024
The antiviral potential of the antiandrogen enzalutamide and the viral-androgen signaling interplay in seasonal coronavirusesOluwadamilola D Ogunjinmi, Tukur Abdullahi, Riaz-Ali Somji, et al.
Endocrinology|June 17, 2006
The endocrine-disrupting compound, nonylphenol, inhibits neurotrophin-dependent neurite outgrowthCassandra L Bevan, Donna M Porter, Christopher R Schumann, et al.
Biochemical Society Transactions|November 1, 2006
Mechanisms of androgen receptor repression in prostate cancerS M Powell, G N Brooke, H C Whitaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2019
Building a synthetic mechanosensitive signaling pathway in compartmentalized artificial cellsJames W Hindley, Daniela G Zheleva, Yuval Elani, et al.
Molecular Oncology|May 24, 2025
Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesisDamien A Leach, Nilesh Chatterjee, Kellie Spahr, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
European Journal of Clinical Investigation|August 24, 1999
Induction of myocardial nitric oxide synthase by Coxsackie B3 virus in miceN M Robinson, H Y Zhang, A L Bevan, et al.
The EMBO Journal|September 8, 2025
Resistance to CDK7 inhibitors directed by acquired mutation of a conserved residue in cancer cellsChun-Fui Lai, Victoria I Cushing, Ellen Olden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogensHayley C Whitaker, Sarah Hanrahan, Nick Totty, et al.
Nursing Ethics|May 8, 2012
Critical social theory approach to disclosure of genomic incidental findingsJeffrey L Bevan, Julia N Senn-Reeves, Ben R Inventor, et al.
Oncogene|February 18, 2004
Androgens target prohibitin to regulate proliferation of prostate cancer cellsSimon C Gamble, Michael Odontiadis, Jonathan Waxman, et al.
Journal of Medical Virology|March 26, 2024
The antiviral potential of the antiandrogen enzalutamide and the viral-androgen signaling interplay in seasonal coronavirusesOluwadamilola D Ogunjinmi, Tukur Abdullahi, Riaz-Ali Somji, et al.
Endocrinology|June 17, 2006
The endocrine-disrupting compound, nonylphenol, inhibits neurotrophin-dependent neurite outgrowthCassandra L Bevan, Donna M Porter, Christopher R Schumann, et al.
Biochemical Society Transactions|November 1, 2006
Mechanisms of androgen receptor repression in prostate cancerS M Powell, G N Brooke, H C Whitaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2019
Building a synthetic mechanosensitive signaling pathway in compartmentalized artificial cellsJames W Hindley, Daniela G Zheleva, Yuval Elani, et al.
Molecular Oncology|May 24, 2025
Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesisDamien A Leach, Nilesh Chatterjee, Kellie Spahr, et al.
Pageof 14